Marbofloxacin

Jump to: navigation, search
Marbofloxacin
Marbofloxacin.PNG
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
oral
ATCvet code
Legal status
Legal status
  • Veterinary use only
Identifiers
CAS Number
ChemSpider
UNII
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H19FN4O4
Molar mass362.356
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Marbofloxacin

Articles

Most recent articles on Marbofloxacin

Most cited articles on Marbofloxacin

Review articles on Marbofloxacin

Articles on Marbofloxacin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Marbofloxacin

Images of Marbofloxacin

Photos of Marbofloxacin

Podcasts & MP3s on Marbofloxacin

Videos on Marbofloxacin

Evidence Based Medicine

Cochrane Collaboration on Marbofloxacin

Bandolier on Marbofloxacin

TRIP on Marbofloxacin

Clinical Trials

Ongoing Trials on Marbofloxacin at Clinical Trials.gov

Trial results on Marbofloxacin

Clinical Trials on Marbofloxacin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Marbofloxacin

NICE Guidance on Marbofloxacin

NHS PRODIGY Guidance

FDA on Marbofloxacin

CDC on Marbofloxacin

Books

Books on Marbofloxacin

News

Marbofloxacin in the news

Be alerted to news on Marbofloxacin

News trends on Marbofloxacin

Commentary

Blogs on Marbofloxacin

Definitions

Definitions of Marbofloxacin

Patient Resources / Community

Patient resources on Marbofloxacin

Discussion groups on Marbofloxacin

Patient Handouts on Marbofloxacin

Directions to Hospitals Treating Marbofloxacin

Risk calculators and risk factors for Marbofloxacin

Healthcare Provider Resources

Symptoms of Marbofloxacin

Causes & Risk Factors for Marbofloxacin

Diagnostic studies for Marbofloxacin

Treatment of Marbofloxacin

Continuing Medical Education (CME)

CME Programs on Marbofloxacin

International

Marbofloxacin en Espanol

Marbofloxacin en Francais

Business

Marbofloxacin in the Marketplace

Patents on Marbofloxacin

Experimental / Informatics

List of terms related to Marbofloxacin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Marbofloxacin is a carboxylic acid derivative third generation fluoroquinolone antibiotic. It is used in veterinary medicine under the trade names Marbocyl,Forcyl and Zeniquin. A formulation of marbofloxacin combined with clotrimazole and dexamethasone is available under the name Aurizon (CAS number 115550-35-1).

Mechanism of action

Its mechanism of action is not thoroughly understood, but it is believed to be similar to the other fluoroquinolones by impairing the bacterial DNA gyrase which results in rapid bactericidal activity.[1] The other proposed mechanisms include that it acts against nondividing bacteria and does not require protein and RNA synthesis, which block protein and RNA synthesis respectively.[2]

Activity

Marbofloxacin is a synthetic, broad spectrum bactericidal agent. The bactericidal activity of marbofloxacin is concentration dependent, with susceptible bacteria cell death occurring within 20–30 minutes of exposure. Like other fluoroquinolones, marbofloxacin has demonstrated a significant post-antibiotic effect for both gram–and + bacteria and is active in both stationary and growth phases of bacterial replication.[3]

It has good activity against many gram-negative bacilli and cocci, is effective against:

Pseudomonas aeruginosa

Klebsiella spp

Escherichia coli

Enterobacter

Campylobacter

Shigella

Salmonella

Aeromonas

Haemophilus

Proteus

Yersinia

Serratia

Vibrio

Brucella

Chlamydia trachomatis

Staphylococci (including penicillinase-producing and methicillin-resistant strains)

Mycoplasma

Mycobacterium

Application

Marbofloxacin can be used both orally and topically. It is particularly used for infections of the skin, respiratory system and mammary glands in dogs and cats, as well as with urinary tract infections. For dogs, a dose ranges from 2.75 - 5.5 mg/kg once a day. The duration of treatment is usually at least five days, longer if there is a concurrent fungal or yeast infection.[4] Maximum duration of treatment is 30 days.[3]

Contraindications and side effects

Marbofloxacin should usually be avoided in young animals because of potential cartilage abnormalities. In rare occasion, it can cause CNS stimulation and should be used with caution in patients with seizure disorders.[3] Under certain conditions it can cause discomfort such as cramps, treatable with diazepam. Other adverse effects are usually limited to GI distress (vomiting, anorexia, soft stools, diarrhoea) and decreased activity.[3]

See also

References

  1. Boothe, D.M. (2001) Antimicrobial drugs. In Small Animal ClinicalPharmacology and Therapeutics, pp. 150–173. W. B. Saunders Co.,Philadelphia, PA.
  2. Hunter RP, Koch DE, Coke RL, Carpenter JW, Isaza R. Identification and comparison of marbofloxacin metabolites from the plasma of ball pythons (Python regius) and blue and gold macaws (Ara ararauna). J Vet Pharmacol Ther. 2007 Jun;30(3):257-62.
  3. 3.0 3.1 3.2 3.3 Plumb DC (ed). Plumb's Veterinary Handbook, 7th ed. Ames, IA: Wiley-Blackwell Publishing, 2011.
  4. Rougier S, Borell D, Pheulpin S, Woehrlé F, Boisramé B (October 2005). "A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa". Vet. Dermatol. 16 (5): 299–307. doi:10.1111/j.1365-3164.2005.00465.x. PMID 16238809.

External links


Linked-in.jpg